Higher Absolute Lymphocyte Counts and Lower Des-γ-Carboxyprothrombin Levels After Treatment Initiation Are Associated With the Clinical Efficacy of Tremelimumab Plus Durvalumab Combination Therapy for Hepatocellular Carcinoma
治疗开始后较高的绝对淋巴细胞计数和较低的去羧基凝血酶原水平与曲美利单抗联合度伐利尤单抗治疗肝细胞癌的临床疗效相关。
期刊:JGH Open
影响因子:1.5
doi:10.1002/jgh3.70123
Inoue, Yuta; Yano, Yoshihiko; Kushida, Saeko; Hirohata, Seiya; Yoon, Seitetsu; Yasutomi, Eiichiro; Hirano, Hirotaka; Kim, Soo Ki; Yoshida, Ryutaro; Ueda, Yoshihide; Momose, Kenji; Hayashi, Hiroki; Kado, Takuo; Nishi, Katsuhisa; Tanaka, Hidenori; Matono, Tomomitsu; Yamamoto, Atsushi; Tei, Hiroshi; Nishioka, Chiharu; Yagi, Yosuke; Tamura, Shoji; Sakane, Tatsuya; Ehara, Mayumi; Kawano, Miki; Kitadai, Jun; Matsuura, Takanori; Shiomi, Yuuki; Komatsu, Shohei; Fukumoto, Takumi; Tada, Toshifumi; Kodama, Yuzo
